Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: lipid lowering agent (Click to remove) Toxic and Drug-Induced Myopathies JNNP 80:832-838, Dalakas,M.C., 2009 Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs JAMA 292:2585-2590, Graham,D.J.,et al, 2004 Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001 Peripheral Neuropathy with Bezafibrate BMJ 309:929, Ellis,C.J.,et al, 1994 HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy Ann Int Med 120:970, Jacobs,M.B., 1994 Gemfibrozil-Induced Myopathy Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991 Cholesterol-Lowering Agent Myopathy (CLAM) Neurol 41:1159-1160, London,S.F.,et al, 1991 Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy JAMA 264:71-75, Pierce,L.R.,et al, 1990 Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy NEJM 296:942, Smals,A.G.H., 1977 Showing articles 0 to 9 of 9